Epidemiological aspects of heart diseases

Aimin Shi, Ziqi Tao, Peng Wei, Jing Zhao, Aimin Shi, Ziqi Tao, Peng Wei, Jing Zhao

Abstract

Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide. Coronary heart disease (CHD) is the main cause of mortality in heart patients following stroke, rheumatic heart disease and myocardial infarctions. Approximately 80% of individuals succumb to CVDs, due to poor living conditions in low and middle income families and malnutrition. Infectious diseases, human immunodeficiency, tuberculosis, malaria, high blood pressure or hypertension, obesity and overweight, and nutritional disorders including smoking, excessive alcohol consumption, high salt and sugar intake, as well as other factors are responsible for CVDs and CHDs in young as well as elderly individuals. The focus of the present review are recent epidemiological aspects of CVD and CHD as well as the usefulness of a Mediterranean diet for heart patients and the prevention of heart diseases.

Keywords: cardiovascular diseases; coronary heart disease; rheumatic heart disease.

References

    1. Adeyi O, Smith O, Robles S. Public policy and the challenge of chronic noncommunicable diseases. The World Bank; Washington, DC: 2007.
    1. WHO Expert Committee on Problems Related To Alcohol Consumption. Second Report, corp-author. World Health Organization Technical Report Series. World Health Organization; Geneva: 2007. pp. 1–65. Mongolian STEPS Survey on the Prevalence of Noncommunicable Disease Risk Factors 2006. World Health Organization Western Pacific Region, Manila, Philippines, 2007.
    1. World Health Statistics 2009, corp-author. WHOSIS (World Health Organization Statistical Information System) World Health Organization; Geneva: 2009. pp. 1–149.
    1. The Current Evidence For The Burden Of Group A Streptococcal Diseases. Discussion Papers On Child Health, corp-author. World Health Organization. Department of Child and Adolescent Health and Development; Geneva: 2005. pp. 1–60.
    1. Beaglehole R, Bonita R. Global public health: a scorecard. Lancet. 2008;372:1988–1996. doi: 10.1016/S0140-6736(08)61558-5.
    1. Fuster V, Kelly BB, editors. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. National Academies Press; Washington, DC: 2015. Epidemiology of cardiovascular disease.
    1. Leeder S, Raymond S, Greenberg H, Liu H, Esson K. Developing Economics. Columbia University; New York, NY: 2004. A Race Against Time: The Challenge Of Cardiovascular Disease; pp. 1–54.
    1. Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect. 1995;103(Suppl 8):131–142. doi: 10.2307/3432300.
    1. Clarke R, Emberson J, Fletcher A, Breeze E, Marmot M, Shipley MJ. Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study. BMJ. 2009;339:b3513. doi: 10.1136/bmj.b3513.
    1. Shafey O, Eriksen M, Ross H, Mackay J. The tobacco atlas. 3rd. American Cancer Society; Atlanta: 2009.
    1. WHO, corp-author. . Childhood overweight and obesity. 2008 Accessed December 12, 2008. The Global Burden Of Disease: 2004 Update. World Health Organization Geneva, 2008. Who Report On The Global Tobacco Epidemic, 2008: The Mpower Package. World Health Organization, Geneva.
    1. Reddy SP, Panday S, Swart D, Jinabhai CC, Amosun SL, James S, Monyeki KD, Stevens G, Morejele N, Kambaran NS, et al. Umthenthe uhlaba usamila: the South African Youth Risk Behavior Survey 2002. South African Medical Research Council; Cape Town: 2003.
    1. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(Suppl 1):S9–S30. doi: 10.1210/jc.2008-1595.
    1. Bhardwaj S, Misra A, Khurana L, Gulati S, Shah P, Vikram NK. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation. Asia Pac J Clin Nutr. 2008;17(Suppl 1):172–175.
    1. Hu FB. Globalization of food patterns and cardiovascular disease risk. Circulation. 2008;118:1913–1914. doi: 10.1161/CIRCULATIONAHA.108.808493.
    1. Khan M, Mensah G. Background Paper Commissioned by the Committee. Purchase, NY: 2009. Changing practices to improve dietary outcomes and reduce cardiovascular risk: a food company's perspective.
    1. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ. 1993;307:1524–1527. doi: 10.1136/bmj.307.6918.1524.
    1. Celermajer DS, Ayer JG. Childhood risk factors for adult cardiovascular disease and primary prevention in childhood. Heart. 2006;92:1701–1706. doi: 10.1136/hrt.2005.081760.
    1. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics. 2001;108:712–718. doi: 10.1542/peds.108.3.712.
    1. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP, III, Herderick EE, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281:727–735. doi: 10.1001/jama.281.8.727.
    1. Smith GD, McCarron P, Okasha M, McEwen J. Social circumstances in childhood and cardiovascular disease mortality: prospective observational study of Glasgow University students. J Epidemiol Community Health. 2001;55:340–341. doi: 10.1136/jech.55.5.340.
    1. Galobardes B, Smith GD, Lynch JW. Systematic review of the influence of childhood socioeconomic circumstances on risk for cardiovascular disease in adulthood. Ann Epidemiol. 2006;16:91–104. doi: 10.1016/j.annepidem.2005.06.053.
    1. Myint PK, Luben RN, Wareham NJ, Bingham SA, Khaw KT. Combined effect of health behaviours and risk of first ever stroke in 20,040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): Prospective population study. BMJ. 2009;338:b349. doi: 10.1136/bmj.b349.
    1. Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation. 2008;118:947–954. doi: 10.1161/CIRCULATIONAHA.108.781062.
    1. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23:363–384. doi: 10.1038/jhh.2008.144.
    1. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamb J, Al-Hinai A, Keltai M, Yusuf S. INTERHEART Study Investigators: Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation. 2008;118:1929–1937. doi: 10.1161/CIRCULATIONAHA.107.738716.
    1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223–2233. doi: 10.1016/S0140-6736(09)60746-7.
    1. Mukamal KJ, Chiuve SE, Rimm EB, Mukamal KJ, Chiuve SE, Rimm EB. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med. 2006;166:2145–2150. doi: 10.1001/archinte.166.19.2145.
    1. Who Technical Report Series. World Health Organization; Geneva: 2003. Diet, Nutrition And The Prevention Of Chronic Diseases: Report Of A Joint Who/Fao Expert Consultation.
    1. Sassi F, Cecchini M, Lauer J, Chisholm D. Tackling Obesity: The Health And Economic Impact Of Prevention Strategies. Organisation for Economic Co-operation and Development; Paris: 2009. Improving Lifestyles.
    1. Caballero B. A nutrition paradox-underweight and obesity in developing countries. N Engl J Med. 2005;352:1514–1516. doi: 10.1056/NEJMp048310.
    1. Wang L, Qi X, Chen C, Ma J, Li L, Rao K, Kong L, Ma G, Xiang H, Pu J, et al., editors. Survey and report on the status of nutrition and health of the Chinese people: a comprehensive report for 2002. People's Medical Publishing House; Beijing: 2005.
    1. Office of the National Statistics. Report. 2003
    1. Lawes CMM, Vander Hoorn S, Rodgers A. International Society of Hypertension: Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–1518. doi: 10.1016/S0140-6736(08)60655-8.
    1. He J, Gu D, Chen J, Wu X, Kelly TN, Huang JF, Chen JC, Chen CS, Bazzano LA, Reynolds K, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet. 2009;374:1765–1772. doi: 10.1016/S0140-6736(09)61199-5.
    1. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC, Koplan JP. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372:1697–1705. doi: 10.1016/S0140-6736(08)61366-5.
    1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J., II Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50. doi: 10.7326/0003-4819-55-1-33.
    1. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971;74:1–12. doi: 10.7326/0003-4819-74-1-1.
    1. Gotto AM., Jr Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F. Bishop lecture. J Am Coll Cardiol. 2005;46:1219–1224. doi: 10.1016/j.jacc.2005.06.059.
    1. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85:37–45. doi: 10.1161/01.CIR.85.1.37.
    1. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM., Jr for the AFCAPS/TexCAPS Research Group: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615–1622. doi: 10.1001/jama.279.20.1615.
    1. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001–1009. doi: 10.1056/NEJM199610033351401.
    1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307. doi: 10.1056/NEJM199511163332001.
    1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952. doi: 10.1016/S0140-6736(04)17018-9.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global burden of disease and risk factors. World Bank; Washington, DC: 2006.
    1. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006b;368:29–36. doi: 10.1016/S0140-6736(06)68967-8.
    1. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73–78. doi: 10.1136/bmj.38678.389583.7C.
    1. Lichtman JH, Bigger JT, Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES. American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association: Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–1775. doi: 10.1161/CIRCULATIONAHA.108.190769.
    1. Figueredo VM. The time has come for physicians to take notice: the impact of psychosocial stressors on the heart. Am J Med. 2009;122:704–712. doi: 10.1016/j.amjmed.2009.05.001.
    1. Brook RD. Cardiovascular effects of air pollution. Clin Sci (Lond) 2008;115:175–187. doi: 10.1042/CS20070444.
    1. Pope CA, III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71–77. doi: 10.1161/01.CIR.0000108927.80044.7F.
    1. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, et al. American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007;115:2878–2901. doi: 10.1161/CIRCULATIONAHA.107.183679.
    1. Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet. 2003a;362:507–515. doi: 10.1016/S0140-6736(03)14109-8.
    1. Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11:276–289. doi: 10.1038/nrcardio.2014.26.
    1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146. doi: 10.1161/CIRCULATIONAHA.107.187998.
    1. Sliwa K, Mayosi BM. Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart. 2013;99:1317–1322. doi: 10.1136/heartjnl-2013-303592.
    1. Mediterranean Diet. American Heart Association; Aug 11, 2014. Updated.
    1. Pearson TA. Recent Advances in Preventive Cardiology and Lifestyle Medicine. Public Policy Approaches to the Prevention of Heart Disease and Stroke. Circulation. 2011;124:2560–2571. doi: 10.1161/CIRCULATIONAHA.110.968743.
    1. The Victoria Declaration On Heart Health Victoria. Health and Welfare Canada; Victoria, Canada: 1992.
    1. The Osaka Declaration, corp-author. Health, Economics, And Political Action: Stemming The Global Tide Of Cardiovascular Disease. Declaration of the Fourth International Heart Health Conference; Osaka (Japan): May, 2001. Health Canada, 2001.
    1. Elixhauser A, Yu K, Steiner C, Bierman AS. HCUP Fact Book No. 1. Agency for Healthcare Research and Quality; Rockville, MD: 2000. Most Common reasons for hospitalizations by age groups. Hospitalization in the United States, 1997; p. 13.
    1. Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, Burke GL, Lima JA. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:2138–2145. doi: 10.1001/archinte.168.19.2138.
    1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35:2950–2959. doi: 10.1093/eurheartj/ehu299.
    1. Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101:1182–1189. doi: 10.1136/heartjnl-2015-307516.
    1. Vasan Ramachandran S, Peter WF. Wilson: Epidemiology and causes of heartfailure. Wolters Kluwer Health Clinical Solutions. 2015

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren